Isolation and characterization of bone cells from a patient with osteogenesis imperfecta type 1b
Abstract
The metabolic defect(s) in bone cells which manifests itself in the disease osteogenesis imperfecta (OI) type 1 is not known. Since this form of the disease displays both a variable tissue involvement and the possibility of remission it is difficult to attribute its expression to a primary mutation in the structural gene for type I collagen (as can the perinatal lethal forms of OI). In an attempt to more fully understand OI type 1 we have isolated and characterized a subpopulation of cells obtained from a sample of bone from a patient with OI type 1b. This subpopulation of cells has been shown to morphologically resemble the osteoblast phenotype, to contain the highest level of alkaline phosphatase of the cells isolated, to synthesize collagen, to respond to bone target hormones such as 1,25(OH)2D3 and parathyroid hormone, and to proliferate rapidly. Moreover, the response of these cells to the vitamin D metabolites, from the standpoint of growth regulation, is qualitatively different from normal bone cells. We intend to use these cells as a model system for studying the defect in OI type 1b.
Read the paper
Related studies
- Development of a crushable foam model for human trabecular bone
- Data-driven motion compensation in HR-pQCT.
- Modeling of structure, quality, and function in the orthodontic patient
- Exploring the mechanism of Heidihuang Pill in the treatment of osteoporosis based on network pharmacology, molecular docking, and experimental validation
- Effect of fabric on the accuracy of computed tomography-based finite element analyses of the vertebra
- Use of interventions involving virtual reality tasks during the climacteric: a systematic review
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.